DE60035687D1 - Bipolare lipide und ihre verwendung zum transport bioaktiver substanzen - Google Patents

Bipolare lipide und ihre verwendung zum transport bioaktiver substanzen

Info

Publication number
DE60035687D1
DE60035687D1 DE60035687T DE60035687T DE60035687D1 DE 60035687 D1 DE60035687 D1 DE 60035687D1 DE 60035687 T DE60035687 T DE 60035687T DE 60035687 T DE60035687 T DE 60035687T DE 60035687 D1 DE60035687 D1 DE 60035687D1
Authority
DE
Germany
Prior art keywords
lipids
bioactive substances
transport
bipolar
bipolar lipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60035687T
Other languages
English (en)
Other versions
DE60035687T2 (de
Inventor
Ian Blagbrough
Andrew John Geall
Michael Anthony William Eaton
Timothy John Norman
Terence Seward The Mayes Baker
Andrew Neil Charles Weir
Catherine Fiona Catterall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Pharma SA
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909582.0A external-priority patent/GB9909582D0/en
Priority claimed from GBGB9924257.0A external-priority patent/GB9924257D0/en
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Publication of DE60035687D1 publication Critical patent/DE60035687D1/de
Application granted granted Critical
Publication of DE60035687T2 publication Critical patent/DE60035687T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60035687T 1999-04-26 2000-04-26 Bipolare lipide und ihre verwendung zum transport bioaktiver substanzen Expired - Fee Related DE60035687T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9909582.0A GB9909582D0 (en) 1999-04-26 1999-04-26 Chemical compounds
GB9909582 1999-04-26
GB9924257 1999-10-13
GBGB9924257.0A GB9924257D0 (en) 1999-10-13 1999-10-13 Chemical compounds
PCT/GB2000/001613 WO2000064858A1 (en) 1999-04-26 2000-04-26 Bipolar lipids and their use for the delivery of bioactive substances

Publications (2)

Publication Number Publication Date
DE60035687D1 true DE60035687D1 (de) 2007-09-06
DE60035687T2 DE60035687T2 (de) 2008-06-05

Family

ID=26315471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60035687T Expired - Fee Related DE60035687T2 (de) 1999-04-26 2000-04-26 Bipolare lipide und ihre verwendung zum transport bioaktiver substanzen

Country Status (6)

Country Link
EP (1) EP1187807B1 (de)
AT (1) ATE368027T1 (de)
AU (1) AU4421200A (de)
DE (1) DE60035687T2 (de)
ES (1) ES2288472T3 (de)
WO (1) WO2000064858A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE383331T1 (de) 1998-11-12 2008-01-15 Invitrogen Corp Transportreagentien
GB9919338D0 (en) 1999-08-16 1999-10-20 Celltech Therapeutics Ltd Biological products
FR2878846B1 (fr) * 2004-12-07 2007-02-23 Enscr Composes analogues de lipides membranaires d'archaebacteries et compositions liposomiales integrant de tel composes
EP3169310A1 (de) 2014-07-15 2017-05-24 Life Technologies Corporation Zusammensetzungen mit lipidaggregaten und verfahren zur effizienten bereitstellung von molekülen an zellen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727679B1 (fr) * 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
US6281371B1 (en) * 1997-08-13 2001-08-28 Biontex Laboratories Gmbh Lipopolyamines, and the preparation and use thereof
US6583301B1 (en) * 1998-04-08 2003-06-24 Celltech R & D Limited Lipids

Also Published As

Publication number Publication date
EP1187807A1 (de) 2002-03-20
WO2000064858A1 (en) 2000-11-02
ATE368027T1 (de) 2007-08-15
DE60035687T2 (de) 2008-06-05
ES2288472T3 (es) 2008-01-16
EP1187807B1 (de) 2007-07-25
AU4421200A (en) 2000-11-10

Similar Documents

Publication Publication Date Title
CY1105416T1 (el) Μεθοδος παρασκευης πολυαλκυλενιμινων που φερουν λειτουργικη ομαδα, συνθεσεις που τις πepιεχουν και οι χρησεις τους
WO2006083799A3 (en) Suspending vehicles comprising a hydrophilic solvent, a hydrophobic solvent, a polymer and the suitable pump-driven dosage form
DE60231549D1 (de) Stabilisierte umkehr-mizellen-zusammensetzungen und ihre verwendung
ATE308621T1 (de) Replizierende retrovirale konstrukte, ihre herstellung und verwendungen für den gentransfer
DE69534669D1 (de) Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung
ES2058420T3 (es) Preparados farmaceuticos combinados y su utilizacion como medicamentos antineoplasicos.
ATE209902T1 (de) Neue liposomkomplexe mit erhöhter systemischer verabreichung
HK1020756A1 (en) Use of angiogenic factor vegf145 in treating cardiovascular disease
WO1998056370A3 (en) Therapeutic nanospheres
WO1996021470A3 (en) Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy
SI0973819T1 (sl) Neantigenski razvejeni polimerni konjugati
AU2002214596A1 (en) Methods and compositions for nucleic acid delivery
EP2221376A3 (de) Antisense-Modulation von Superoxid-Dismutase 1, Expression in Lösung
WO2008054466A3 (en) Delivery of biologically active materials using core-shell tecto (dendritic polymers)
AU2002311886A1 (en) Process for preparing purified shilajit composition from native shilajit
WO2009044406A3 (en) Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof
ATE284383T1 (de) Verbindungen, ihre herstellung und ihre verwendung für den transfer von nucleinsäuren in zellen
WO1999052858A3 (en) Lipids
WO2023018990A3 (en) Lipids for nucleic acid delivery
DE60035687D1 (de) Bipolare lipide und ihre verwendung zum transport bioaktiver substanzen
ES2167939T3 (es) Nuevas poliaminas, su preparacion y usos.
WO2003047494A3 (en) Reverse micelle compositions and uses thereof
DE59209905D1 (de) Neue protein-polykation-konjugate
EP3467112A3 (de) Verfahren zur transfektion von nukleinsäure in lebende zellen
DE69903436T2 (de) Polyionische hydrogele auf der basis von chitosan und xanthangummi zur stabilisierung und kontrollierter freisetzung von vitaminen

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: UCB PHARMA, S.A., BRUESSEL/BRUXELLES, BE

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee